US 7622587
Crystalline form of a benzimidazole-carboxamide medicinal compound
granted A61PA61P1/00A61P1/10
Quick answer
US patent 7622587 (Crystalline form of a benzimidazole-carboxamide medicinal compound) held by Theravance, Inc. expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/00, A61P1/10, A61P1/14